Loading...
PCSK9 Inhibitors in a Statin-Intolerant Transgender Man With Heterozygous Familial Hypercholesterolemia: A Case Report
In female-to-male transgender individuals, testosterone is used to induce masculinization. Sex steroid therapy may increase circulating triglyceride and low-density lipoprotein cholesterol (LDL-C) levels and may decrease high-density lipoprotein cholesterol (HDL-C) levels, resulting in a more athero...
Saved in:
Published in: | J Endocr Soc |
---|---|
Main Authors: | , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Endocrine Society
2019
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6665951/ https://ncbi.nlm.nih.gov/pubmed/31380502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00070 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|